Document:

Exhibit
10.04

 

Execution
Version

 

EXECUTIVE
EMPLOYMENT AGREEMENT

 

THIS
EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into by and between on the one hand SRAX,
Inc., a Delaware corporation (the “Parent”), and its wholly owned subsidiary, LD Micro, Inc., a Delaware corporation
(the “Company”), and on the other hand Christopher Lahiji (the “Executive”), as of the 4th
day of September, 2020 and made effective as of the Merger Closing Date (as defined below) (the “Effective Date”).

 

WHEREAS,
pursuant to the terms and conditions of that certain Agreement and Plan of Merger and Reorganization, dated September 4, 2020
(the “Merger Agreement”), by and among the Parent, the Company, Townsgate Merger Sub 1, Inc., a Delaware corporation
and wholly owned subsidiary of the Parent (“Merger Sub 1”), LD Micro, Inc., a California corporation (“Target”),
and Christopher Lahiji, as the sole stockholder of Target, Merger Sub 1 will merge with and into Target, and then Target will
merge with and into the Company, with the Company continuing as the surviving corporation and as a wholly owned subsidiary of
the Parent (the “Merger” and such date, the “Merger Closing Date”);

 

WHEREAS,
prior to the Merger, the Executive has been employed by the Target;

 

WHEREAS,
the Parent and the Company desire to employ the Executive as the President of the Company upon consummation of the Merger; and

 

WHEREAS,
in consideration of the Executive’s employment with the Company, the Company desires to provide the Executive with certain
compensation and benefits as set forth in this Agreement.

 

NOW,
THEREFORE, for and in consideration of the premises, the mutual promises, covenants and agreements contained herein, and for other
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1.
Employment. Subject to the terms and conditions set forth in this Agreement, the Company hereby offers the Executive, and
the Executive hereby accepts, employment with the Company.

 

2.
Term. Subject to earlier termination as hereafter provided, the Executive’s employment hereunder shall be for an
initial term of three (3) years (the “Initial Term”), commencing as of the Effective Date, and shall automatically
renew thereafter for successive terms of one (1) year each (each, a “Renewal Term”), unless one of the parties
hereto gives written notice of termination to the other party at least sixty (60) days prior to the last day of the Initial Term
or the then-current Renewal Term, as applicable. The Initial Term, together with any Renewal Terms thereof, are hereafter referred
to, collectively, as “the term of this Agreement” or “the term hereof.”

 

3.
Capacity and Performance.

 

(a)
Commencing on the Effective Date, the Executive shall serve the Company as its President. The Executive shall report to the Parent’s
Chief Executive Officer and perform such duties and responsibilities as may be prescribed from time to time. The Executive shall
be appointed as a member of the Parent’s Board of Directors (the “Board”), and thereafter, during the
term of this Agreement, the Parent shall cause the nominating and corporate governance committee of the Board (the “Nominating
Committee”) to nominate the Executive to serve as a member of the Board each year the Executive’s term of Board
service is to be slated for reelection to the Board. If the Parent’s stockholders vote in favor of the Nominating Committee’s
nomination of the Executive to serve as a member of the Board, the Executive agrees to serve in such capacity. So long as the
Executive continues to serve as a member of the Board, he shall be entitled to receive, in addition to the compensation payable
to him as President under this Agreement, compensation and benefits on the same basis as provided to all other executive members
of the Board. The Executive agrees to submit written notice of resignation of his directorship to the Board, effective as of the
date on which Executive ceases to serve as President of the Company.

 

    	1

     

    

 

(b)
During the term hereof, the Executive shall be employed by the Company on a full-time basis. He shall have the duties, responsibilities
and authority of President of the Company and such other duties, responsibilities and authority, reasonably consistent with that
position, with respect to the business operations of the Company, as may be assigned by the Parent’s Chief Executive Officer
from time to time.

 

(c)
During the term hereof, the Executive shall devote his full business time and best efforts, business judgment, skill and knowledge
to the advancement of the business and interests of the Company. During the term of this Agreement, the Executive may engage in
passive management of his personal investments and in such community and charitable activities as do not individually or in the
aggregate give rise to a conflict of interest or otherwise interfere with his performance of his duties and responsibilities hereunder.
It is agreed that the Executive may accept membership on a board of directors or other governing board of any Person (as defined
in Section 10 hereof) so as long as such position does not conflict or interfere or deter the Executive from performing
his duties to the Company.

 

4.
Compensation and Benefits. As compensation for services performed by the Executive as President of the Company pursuant
to and during the term of this Agreement:

 

(a)
Base Salary. Initially during the term hereof, the Company shall pay the Executive a base salary at the rate of Three Hundred
Thirty-Five Thousand Dollars ($335,000.00) per annum, payable in accordance with the payroll practices of the Company for its
executives and subject to annual review by the Board or the compensation committee thereof. The Executive’s base salary
is hereafter referred to as the “Base Salary.” The Base Salary shall not be reduced without the prior written
consent of the Executive, but may be increased, from time to time, by the Board.

 

(b)
Annual Bonus Compensation. With respect to each full fiscal year of the Company occurring during the term of this Agreement
(or pro-rated for the Company’s 2020 fiscal year and any other fiscal year where the term of this Agreement expires or is
terminated prior to the last day of such fiscal year) or as otherwise provided herein, the Executive shall be eligible to earn
under the Parent’s annual bonus plan in effect for senior executive officers of the Company and/or the Parent (the “Bonus
Plan”) an annual bonus award (the “Annual Bonus”) in a target amount equal to 15% of his Base Salary
(the “Target Bonus”), based upon the achievement, as determined by the Compensation Committee, by the Company
and/or the Executive of annual performance targets established by the Compensation Committee of the Board (the “Compensation
Committee”) in its reasonable good faith discretion. Any Annual Bonus payable in respect of the initial fiscal year,
or any other fiscal year where the term of this Agreement expires or is terminated prior to the last day of such fiscal year,
will be pro-rated to reflect the number of days of employment hereunder during such period. Any Annual Bonus for a fiscal year
in which the Executive is employed at the end of such fiscal year under this Agreement shall be paid in full to the Executive
by March 15 of the following fiscal year, regardless of whether the Executive remains employed under this Agreement at such time.
Any Annual Bonus payable in respect of any fiscal year where the term of this Agreement expires or is terminated prior to the
last day of such fiscal year shall be paid in full to the Executive no later than thirty (30) days following the date of such
expiration or termination.

 

    	2

     

    

 

(c)
Equity Participation. The Executive shall receive equity incentive award grants (“Equity Awards”) of
the types, in the amounts and on a basis commensurate with the equity incentive awards granted to similarly-situated executive
officers of the Parent.

 

(d)
Other Benefits. During the term hereof, the Executive shall be entitled to participate in all health and welfare plans
and retirement plans, from time to time in effect for executives of the Company and the Parent generally, subject to all eligibility
requirements. The Executive’s participation in such plans shall be subject to the generally applicable Company policies.
Any such benefits, plans and policies are subject to change or termination from time to time as determined by the Board.

 

(e)
All Purpose Days. The Executive will be entitled to thirty (30) all-purpose days per year, to be taken at such times and
intervals as shall be determined by the Executive, subject to the reasonable business needs of the Company. Such all-purpose days
shall be governed by the policies of the Company, as in effect from time to time.

 

(f)
Business Expenses. The Company will pay or reimburse the Executive within thirty (30) days of the Company’s receipt
of a reasonably detailed expense report for all reasonable, customary and necessary business expenses incurred or paid by the
Executive in the performance of his duties and responsibilities hereunder, subject to any maximum annual limit and other restrictions
on such expenses set by the Board, to such reasonable substantiation, documentation and submission deadlines as may be specified
by the Company from time to time.

 

(g)
Remote Office Allowance. During the term hereof, the Company shall provide the Executive with a remote office allowance
and related expenses in the amount of One Thousand Dollars ($1,000) per month.

 

(h)
Directors and Officers Insurance Coverage. During the term hereof, the Company shall provide the Executive the same rights
of indemnification and contribution and the same coverage under any directors and officers (“D&O”) liability
insurance which the Company and the Parent provides to its other executives and, after the termination of his employment hereunder,
the Company and the Parent shall provide the Executive the same rights of indemnification and contribution, and the same coverage
under any D&O liability insurance it provides to its other former executives.

 

(i)
Clawback Provisions. Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based or other
compensation paid to the Executive under this Agreement or any other agreement or arrangement with the Parent or the Company which
is subject to recovery under any law, government regulation, or stock exchange listing requirement will be subject to such deductions
and clawback as may be required to be made pursuant to such law, government regulation, or stock exchange listing requirement
(or any policy adopted by the Parent or the Company pursuant to any such law, government regulation or stock exchange listing
requirement).

 

    	3

     

    

 

5.
Termination of Employment and Severance Benefits. Notwithstanding the provisions of Section 2 hereof, the Executive’s
employment hereunder shall terminate during the term hereof under the following circumstances:

 

(a)
Death. In the event of the Executive’s death during the term hereof, the Executive’s employment hereunder shall
immediately and automatically terminate. In such event, promptly following the date of termination of the Executive’s employment
with the Company (hereafter, the “Date of Termination”), the Company shall promptly pay to his estate the Final
Compensation (as defined in Section 10 hereof).

 

(b)
Disability. The Company may terminate the Executive’s employment hereunder, upon notice to the Executive, in the
event that the Executive becomes disabled during his employment through any illness, injury, accident or condition of either a
physical or psychological nature and, as a result, is unable to perform substantially all of his duties and responsibilities hereunder,
notwithstanding the provision of any reasonable accommodation, for one hundred and eighty (180) days during any period of three
hundred and sixty-five (365) consecutive calendar days. In the event of such termination, Company shall promptly pay to the Executive
the Final Compensation. Any question as to the existence, extent, or potentiality of Executive’s disability upon which Executive
and the Company cannot agree shall be determined by a qualified, independent physician selected by the Parent or the Company and
approved by Executive or, if applicable, his guardian (which approval shall not be unreasonably withheld). The determination of
any such physician shall be final and conclusive for the purposes of this Section 5(b).

 

(c)
By the Company for Cause. The Company may terminate the Executive’s employment hereunder for Cause at any time upon
notice to the Executive setting forth in reasonable detail the nature of such Cause. For purposes of this Agreement, “Cause”
shall be limited to: (i) the Executive’s conviction of, or plea of nolo contendere to a felony or any other crime involving
fraud or material financial dishonesty; (ii) the Executive’s gross negligence or willful misconduct with regard to the Company
which has a material adverse impact on the Company; (iii) the Executive’s refusal or willful failure to substantially perform
his duties or to follow a material lawful written directive of the Parent’s Chief Executive Officer within the scope of
the Executive’s duties hereunder which in either case remains uncured or continues after forty-five (45) days’ written
notice from the Board which references the potential for a “for Cause” termination and specifies in reasonable detail
the nature of the refusal or willful failure which must be cured; or (iv) the Executive’s theft, fraud or any material act
of financial dishonesty related to the Company. In the event of such termination, the Company shall have no obligation to the
Executive under this Agreement except the Final Compensation.

 

(d)
By the Company other than for Cause. The Company may terminate the Executive’s employment hereunder other than for
Cause at any time upon ninety (90) days’ written notice to the Executive. For purposes of clarity, a non-renewal of the
term hereof by Company will not be considered a termination “other than for Cause” and Executive will not have the
right to any severance in such event. In the event of such termination, the Executive shall be entitled to the following:

 

(i)
The Company shall pay the Executive the Final Compensation earned through the Date of Termination and any other compensation and
benefits to the extent actually earned by the Executive under any benefit plan or program of the Company as of the Date of Termination.

 

    	4

     

    

 

(ii)
The Company shall pay to the Executive a total amount equal to twenty four (24) months of the Executive’s then current Base
Salary, less applicable taxes and deductions; to be made in approximately equal biweekly installments in accordance with the Parent’s
usual payroll practices over a period of twenty four (24) months beginning after the effective date of the Release of Claims.
In addition, the Executive shall be entitled to receive all Annual Bonuses for the period from the Date of Termination through
the end of the Initial Term or the then-current Renewal Term, as applicable. The Executive shall have no duty to mitigate any
such payment due.

 

(iii)
Following the Date of Termination, the Company shall pay the full amount of the Executive’s premiums for the Executive’s
continued coverage under the Company’s health and dental plans under COBRA (including coverage for the Executive’s
qualified beneficiaries), until the earliest to occur of (A) the expiration of twenty four (24) months following the Date of Termination;
(B) the date the Executive becomes eligible for participation in health and dental plans of another employer and (C) the date
the Executive ceases to be eligible for participation under the Company’s health and dental plans under COBRA; provided,
however, that, in order to be eligible for the Company’s payments hereunder, the Executive and each of his qualified
beneficiaries must elect in a timely manner to continue coverage under the Company’s health and dental plans under COBRA.
In the event the Company does not provide medical insurance coverage to its employees but instead provides for expense reimbursement
in connection with such premiums, the Company will continue to reimburse the Executive for such premiums for a period of eighteen
(18) months following the Date of Termination.

 

(iv)
All Equity Awards granted to the Executive pursuant to Section 4(c), which are unvested as of the Date of Termination,
shall be accelerated and become fully-vested and non-forfeitable as of the Executive’s last day of employment, provided
Executive signs the Release of Claims, notwithstanding anything to the contrary set forth in any equity plan or award agreements
relating to such Equity Awards.

 

(v)
Notwithstanding the foregoing, the Company’s obligations under clauses (ii), (iii) and (iv) of this Section 5(d)
shall be contingent upon the full execution by the Executive of an effective Release of Claims.

 

(e)
By the Executive for Good Reason.

 

(i)
The Executive may terminate his employment hereunder for Good Reason by providing notice to the Company of the condition giving
rise to the Good Reason no later than sixty (60) days following the occurrence of the condition, by giving the Company thirty
(30) days to remedy the condition and by terminating employment for Good Reason within thirty (30) days thereafter if the Company
fails to remedy the condition.

 

    	5

     

    

 

(ii)
For purposes of this Agreement, “Good Reason” shall mean, without the Executive’s consent, the occurrence
of any one or more of the following events: (A) the material breach of this Agreement by the Company or the Parent which breach
is not cured within thirty (30) days following written notice thereof to the Company of such breach; (B) a material diminution
of the Executive’s title as President of the Company or of any of the Executive’s significant duties, authority or
responsibilities; (C) the Board and/or the Nominating Committee fails to recommend to the Parent’s stockholders that the
Executive should continue to serve as a member of the Board; (D) any reduction in or failure to pay the Base Salary or Annual
Bonus (if earned) other than a general reduction in Base Salary that affects all similarly situated employees in substantially
the same proportion; and/or (E) a significant reduction in the employee benefits provided to the Executive other than in connection
with an across-the-board reduction similarly affecting substantially all senior executives of the Company. Notwithstanding the
foregoing, during the Initial or Renewal Term, in the event that the Company reasonably believes that Executive may have engaged
in conduct that could constitute Cause hereunder, the Company may, in its sole and absolute discretion, suspend the Executive
from performing the Executive’s duties hereunder for a period not to exceed 90 days, and in no event shall such suspension
constitute an event pursuant to which the Executive may terminate employment with Good Reason or otherwise constitute a breach
hereunder; provided, that no such suspension shall alter the Company’s obligations under this Agreement during such period
of suspension. For purposes of clarity, a non-renewal of Executive’s term hereof will not be considered a termination for
“Good Reason” hereunder and Executive will not have the right to any severance in such event.

 

(iii)
In the event of termination in accordance with this Section 5(e), then, in addition to Final Compensation, the Company
shall provide the Executive the same compensation and premium payments under clause (i) of Section 5(d) and, provided
that the Executive fully executes and does not revoke an effective Release of Claims, under clauses (ii) and (iii) of Section
5(d), in each case, as if his employment had been terminated by the Company other than for Cause.

 

(iv)
In the event of termination in accordance with this Section 5(e), all Equity Awards granted to the Executive pursuant to Section
4(c), which are unvested as of the last day of the Executive’s employment, shall be accelerated and become fully-vested
and non-forfeitable as of the Executive’s last day of employment, provided that the Executive fully executes and
does not revoke an effective Release of Claims, as if his employment had been terminated by the Company other than for Cause,
notwithstanding anything to the contrary set forth in any equity plan or award agreements relating to such Equity Awards.

 

(f)
By the Executive Other than for Good Reason. The Executive may terminate his employment hereunder at any time upon sixty
(60) days’ notice to the Company. In the event of termination of the Executive pursuant to this Section 5(f), the
Board may elect to waive the period of notice, or any portion thereof, and, if the Board so elects, the Company will pay the Executive
his Base Salary for the initial sixty (60) days of the notice period (or for any remaining portion thereof). The Company’s
only other obligation to the Executive hereunder shall be for Final Compensation.

 

6.
Effect of Termination. The payments provided for under Section 5, as applicable, shall constitute the entire obligation
of the Company to the Executive hereunder following termination of his employment by the Company; provided, however,
that nothing contained herein shall affect the Executive’s rights to receive distributions of any vested benefits under
any 401(k) plan, any other savings or retirement plan or any other contributory employee benefit plans or arrangements in accordance
with the terms of such plans. Except for health and dental plan participation continued in accordance with COBRA, the Executive’s
participation in the Company’s employee benefit plans shall terminate pursuant to the terms of the applicable policies thereunder
based on the Date of Termination.

 

    	6

     

    

 

7.
Confidential Information.

 

(a)
The Executive acknowledges that the Company and the Parent continually develop Confidential Information (as defined in Section
10 hereof); that the Executive may develop Confidential Information for the Company or the Parent; and that the Executive
may learn of Confidential Information during the course of employment. The Executive will comply with the policies and procedures
of the Company and the Parent for protecting Confidential Information and shall not disclose to any Person or use, other than
as required by applicable law (by way of example, if the Executive is requested to disclose Confidential Information by a validly
issued and served subpoena, after providing the Company an opportunity to object to and oppose disclosure) or for the proper performance
of his duties and responsibilities to the Company and Parent, any Confidential Information obtained by the Executive incident
to his employment or other association with the Company or the Parent.

 

(b)
All documents, records, tapes and other media of every kind and description relating to the business, present or otherwise, of
the Company or the Parent, and any copies, in whole or in part, thereof (the “Documents”), whether or not prepared
by the Executive, shall be the sole and exclusive property of the Company and the Parent. The Executive shall safeguard all Documents
and, as soon as reasonably practicable following termination of his employment or at such earlier time or times as the Board or
its designee may specify, shall surrender to the Company any such Documents in his possession or control, provided, however,
that the Executive will be under no obligation to surrender any Documents acquired from third parties which are generally available
to the public.

 

8.
Assignment of Rights to Intellectual Property. The Executive shall promptly and fully disclose all Intellectual Property
(as defined in Section 10 hereof) to the Company. The Executive hereby assigns and agrees to assign to the Company (or
as otherwise directed by the Company) the Executive’s full right, title and interest in and to all Intellectual Property.
The Executive agrees to execute any and all applications for domestic and foreign patents, copyrights or other proprietary rights
and to do such other acts (including without limitation the execution and delivery of instruments of further assurance or confirmation)
requested by the Company to assign the Intellectual Property to the Company and to permit the Company to enforce any patents,
copyrights or other proprietary rights to the Intellectual Property, including but not limited to entering into the Confidentiality
Agreement. All copyrightable works that the Executive creates during the course of his employment by the Company and which pertain
to the business of the Company or Parent or are suggested by any work performed by the Executive for the Company or Parent or
make use of Confidential Information shall be considered “work made for hire” and, upon creation, shall be owned exclusively
by the Company or the Parent.

 

9.
Conflicting Agreements. The Executive hereby represents and warrants that the execution of this Agreement and the performance
of his obligations hereunder will not breach or be in conflict with any other agreement to which the Executive is a party or is
bound and that the Executive is not now subject to any covenants against competition or similar covenants or any court order or
other legal obligation that would affect the performance of his obligations hereunder. To the extent that any conflicts exist
or arise between the terms of this Agreement and the terms of any other agreement that the Executive has previously entered into
with the Company, the provisions of this Agreement shall govern.

 

    	7

     

    

 

10.
Definitions. Words or phrases which are initially capitalized or are within quotation marks shall have the meanings provided
in this Section and as provided elsewhere herein. For purposes of this Agreement, the following definitions apply:

 

(a)
“Confidential Information” shall mean any and all information of the Company and the Parent that is not generally
known by those with whom the Company or Parent competes or does business, or with whom the Company or Parent plans to compete
or do business, including without limitation (i) information related to the Products, technical data, methods, processes, know-how
and inventions of the Company and the Parent, (ii) the development, research, testing, marketing and financial activities and
strategic plans of the Company and the Parent, (iii) the manner in which they operate, (iv) their costs and sources of supply,
(v) the identity and special needs of the customers of the Company and Parent, and (vi) the persons and entities with whom the
Company and Parent have business relationships and the nature and substance of those relationships. Confidential Information does
not include information that enters the public domain or information that is regularly or commonly known in the industry for which
the Executive will be performing his duties, other than through a breach by the Executive or another Person of an obligation of
confidentiality to the Company or Parent.

 

(b)
“Confidentiality Agreement” shall mean the Company’s Confidentiality Information and Assignment Agreement,
substantially in the form attached hereto as Exhibit B.

 

(c)
“Final Compensation” means (i) Base Salary earned but not paid through the Date of Termination, (ii) pay at
the final rate of the Base Salary for any all purposes days not used through the Date of Termination, (iii) any Annual Bonus earned
but unpaid for the fiscal year preceding that in which, and the fiscal year in which, the Date of Termination occurs, (iv) three
months of remote office allowance, and (v) any business expenses incurred by the Executive but un-reimbursed on the Date of Termination,
provided that such expenses and required substantiation and documentation are submitted prior to, or within sixty (60)
days following, the Date of Termination and that such expenses are reimbursable under Company policy.

 

(d)
“Intellectual Property” means any invention, formula, process, discovery, development, design, innovation or
improvement (whether or not patentable or registrable under copyright statutes) made, conceived, or first actually reduced to
practice by the Executive solely or jointly with others, during his employment by the Company; provided, however,
that, as used in this Agreement the term “Intellectual Property” shall not apply to any invention that the Executive
develops on his own time, without using the equipment, supplies, facilities or trade secret information of the Company or Parent
to which the Executive has access as a result of his employment, unless such invention relates at the time of conception or reduction
to practice of the invention (i) to the business of the Company or the Parent, or (ii) to the actual, or demonstrably anticipated,
research or development of the Company or Parent to which the Executive has access as a result of his employment, or such invention
results from any work performed by the Executive for the Company.

 

(e)
“Person” means an individual, a corporation, a limited liability company, an association, a partnership, an
estate, a trust and any other entity or organization, other than the Company or any of the Parent.

 

    	8

     

    

 

(f)
“Products” means all products planned, researched, developed, tested, manufactured, sold, licensed, leased
or otherwise distributed or put into use by the Company or Parent, together with all services provided or planned by the Company
or Parent, during the Executive’s employment.

 

(g)
“Release of Claims” shall mean a release of claims made by the Executive in favor of the Company, the Parent
and its subsidiaries in the form attached hereto as Exhibit A (with any updates reasonably determined by
the Company to be necessary to comply with applicable law) and the execution of which is a condition precedent to the Executive’s
eligibility for severance benefits as described in Section 5(d).

 

11.
Withholding and Joint and Several Obligation of Company and Parent. Except as otherwise provided herein, all payments made
by the Company under this Agreement shall be reduced by any tax or other amounts required to be withheld by the Company under
applicable law. Any and all payments due to the Executive under this Agreement shall be the joint and several obligations of the
Company and Parent.

 

12.
Compliance with Section 409A of the Code. This Agreement is intended to either comply with, or fall within an exemption
to, the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the
“Code”) and the Treasury regulations relating thereto (“Section 409A”), and shall
be interpreted and construed consistently with such intent. To the maximum extent possible, the payments to the Executive pursuant
to this Agreement are also intended to be exempt from Section 409A of the Code under either the separation pay exemption pursuant
to Treasury regulation § 1.409A-1(b)(9)(iii) or as short-term deferrals pursuant to Treasury regulation § 1.409A-1(b)(4).
In the event the terms of this Agreement would subject the Executive to taxes or penalties under Section 409A of the Code (“409A
Penalties”), the Company and the Executive shall cooperate diligently to amend the terms of this Agreement to avoid
such 409A Penalties, to the extent possible; provided that such amendment shall not increase or reduce (in the aggregate) the
amounts payable to the Executive hereunder. Any taxable reimbursement payable to the Executive pursuant to this Agreement shall
be paid to the Executive no later than the last day of the calendar year following the calendar year in which the Executive incurred
the reimbursable expense. Any amount of expenses eligible for taxable reimbursement, or such in-kind benefit provided, during
a calendar year shall not affect the amount of such expenses eligible for reimbursement, or such in-kind benefit to be provided,
during any other calendar year. The right to such reimbursement or such in-kind benefits pursuant to this Agreement shall not
be subject to liquidation or exchange for any other benefit. Any right to a series of installment payments pursuant to this Agreement
is to be treated as a right to a series of separate payments. If, as of the Date of Termination, the Executive is a “specified
employee” (within the meaning of Section 409A of the Code), then no payment or benefit that is payable on account of the
Executive’s “separation from service” (within the meaning of Section 409A of the Code) shall be made before
the date that is six (6) months after the Executive’s “separation from service” (or, if earlier, the date of
the Executive’s death) if and to the extent that such payment or benefit constitutes deferred compensation (or may be nonqualified
deferred compensation) under Section 409A of the Code and such deferral is required to comply with the requirements of Section
409A of the Code. Any payment or benefit delayed by reason of the prior sentence shall be paid out or provided in a single lump
sum at the end of such required delay period in order to catch up to the original payment schedule.

 

    	9

     

    

 

13.
Assignment. Neither the Company or Parent, on the one hand, nor the Executive, on the other hand, may make any assignment
of this Agreement or any interest herein, by operation of law or otherwise, without the prior written consent of the other party
or parties; provided, however, that the Company may assign its rights and obligations under this Agreement without
the consent of the Executive in the event the Company shall hereafter effect a corporate reorganization, consolidate with, or
merge into, any Person or transfer all or substantially all of its properties or assets to any Person. This Agreement shall inure
to the benefit of and be binding upon the Company, the Parent and the Executive, their respective successors, executors, administrators,
heirs and permitted assigns.

 

14.
Severability. If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by
a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances
other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision
of this Agreement shall be valid and enforceable to the fullest extent permitted by law.

 

15.
Waiver. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The
failure of either party to require the performance of any term or obligation of this Agreement, or the waiver by either party
of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver
of any subsequent breach.

 

16.
Notices. Any and all notices, requests, demands and other communications provided for by this Agreement shall be in writing
and shall be effective when delivered in person, consigned to a reputable national courier or deposited in the United States mail,
postage prepaid, registered or certified, and addressed to the Executive at his last known address on the books of the Company
or, in the case of the Company or the Parent, to their current business addresses, or to such other address as any party may specify
by notice to the other actually received.

 

17.
Entire Agreement. This Agreement, along with the other agreements referred to herein, constitute the entire agreement,
and supersede all prior agreements, whether written or oral, between the Company, the Parent and the Executive with respect to
the Executive’s employment and all related matters.

 

18.
Amendment. This Agreement may be amended or modified only by a written instrument signed by the Executive and by an expressly
authorized representative of the Board.

 

19.
Headings. The headings and captions in this Agreement are for convenience only and in no way define or describe the scope
or content of any provision of this Agreement.

 

20.
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be an original and all of
which together shall constitute one and the same instrument.

 

21.
Governing Law. This Agreement shall be construed and enforced under and be governed in all respects by the laws of the
State of California, without regard to the conflict of laws principles thereof, and, for the avoidance of doubt, shall include
both the statutory and common law of California, except to the extent preempted by federal law.

 

[Remainder
of page intentionally left blank. Signature page follows immediately.]

 

    	10

     

    

 

IN
WITNESS WHEREOF, this Agreement has been executed by the Parent and Company, by its duly authorized representative, and by the
Executive, as of the date first above written.

 

	THE
    EXECUTIVE:	 	SRAX,
    INC.
	 	 	 	 	 
	By:	 	 	By:	 
	Name:	Christopher
    Lahiji	 	Name:	Chris
    Miglino
	 	 	 	Title:	CEO
	 	 	 	 	 
	 	 	 	LD
    MICRO, INC.
	 	 	 	 	 
	 	 	 	By:	 
	 	 	 	Name:	Chris
    Miglino
	 	 	 	Title:	CEO

 

    	 

     

    

 

EXHIBIT
A

 

RELEASE
OF CLAIMS

 

In
exchange for the severance benefits to be provided to me under the Employment Agreement between me, SRAX, Inc. (the “Parent”)
and its wholly-owned subsidiary, LD Micro, Inc., a Delaware corporation (collectively with the Parent, the “Company”),
dated as of September 4, 2020 (the “Employment Agreement”), to which I would not otherwise be entitled, on my own
behalf and that of my heirs, executors, administrators, beneficiaries, personal representatives and assigns, I agree that this
General Release and Waiver of Claims (the “Release of Claims”) shall be in complete and final settlement of any and
all causes of action, rights and claims, whether known or unknown, accrued or unaccrued, contingent or otherwise, that I have
had in the past, now have, or might now have, in any way related to, connected with or arising out of my employment or its termination,
under the Employment Agreement, or pursuant to Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act,
the Age Discrimination in Employment Act, as amended by the Older Workers Benefit Protection Act, the Worker Adjustment and Retraining
Notification Act, the Employee Retirement Income Security Act, the wage and hour, wage payment and fair employment practices laws
and statutes of the State of California (each as amended from time to time), and/or any other federal, state or local law, regulation
or other requirement (collectively, the “Claims”), and I hereby release and forever discharge the Company, its subsidiaries
and all of their respective past, present and future directors, shareholders, officers, members, managers, general and limited
partners, employees, employee benefit plans, administrators, trustees, agents, representatives, successors and assigns, and all
others connected with any of them, both individually and in their official capacities, from, and I hereby waive, any and all such
Claims. Notwithstanding anything to the contrary contained herein, this Release of Claims shall not apply to (a) any claims that
arise after I sign this Release of Claims, including my right to enforce the terms of this Release of Claims; (b) any claims that
may not be waived pursuant to applicable law; (c) any right to indemnification that I may have under the certificate of incorporation
or by-laws of the Company, and any Indemnification Agreement between me and the Company or any insurance policies maintained by
the Company; (d) any right to receive any vested benefits under the terms of any employee benefit plans and my award agreements
thereunder or (e) any failures by the Company to comply with Section 5 of the Employment Agreement.

 

Nothing
contained in this Release of Claims shall be construed to prohibit me from filing a charge with or participating in any investigation
or proceeding conducted by the federal Equal Employment Opportunity Commission or a comparable state or local agency, provided,
however, that I hereby agree to waive my right to recover monetary damages or other individual relief in any charge, complaint
or lawsuit filed by me or by anyone else on my behalf.

 

In
signing this Release of Claims, I acknowledge my understanding that I may consider the terms of this Release of Claims for up
to [twenty-one (21)/forty-five (45)]1 days from the date I receive it and that I may not sign this Release of Claims
until after the date my employment with the Company terminates. I also acknowledge that I am hereby advised by the Company to
seek the advice of an attorney prior to signing this Release of Claims; that I have had sufficient time to consider this Release
of Claims and to consult with an attorney, if I wished to do so, or to consult with any other person of my choosing before signing;
and that I am signing this Release of Claims voluntarily and with a full understanding of its terms.

 

I
further acknowledge that, in signing this Release of Claims, I have not relied on any promises or representations, express or
implied, that are not set forth expressly in the Release of Claims. I understand that I may revoke this Release of Claims at any
time within seven (7) days of the date of my signing by written notice to the Chairman of the Company’s Board of Directors
and that this Release of Claims will take effect only upon the expiration of such seven-day revocation period and only if I have
not timely revoked it.

 

Intending
to be legally bound, I have signed this Release of Claims under seal as of the date written below.

 

Signature
___________________________

 

Name
______________________________

 

Date
Signed _________________________

 

 

1
To be determined by the Company at the time of termination.

 

    	 

     

    

 

EXHIBIT
B

 

CONFIDENTIALITY
INFORMATION AND ASSIGNMENT AGREEMENTExhibit
10.1

 

EXCHANGE
AGREEMENT

 

EXCHANGE
AGREEMENT (the “Agreement”) is made as of September 10, 2020, by and between AMERI Holdings, Inc.,
a Delaware corporation (the “Company”), and the investor signatory hereto (the “Investor”).

 

WHEREAS,
the Investor is the holder of a certain 7.25% Secured Convertible Note issued by the Company on February 24, 2020 in the original
principal amount of $1,000,000, plus accrued interest on such obligations (collectively, the “Existing Securities”);

 

WHEREAS,
the Investor holds the Existing Securities of the Company set forth on the Investor’s signature page attached hereto;

 

WHEREAS,
subject to the terms and conditions set forth in this Agreement and in reliance on Section 3(a)(9) of the Securities Act of 1933,
as amended (the “Securities Act”), the Company desires to exchange with the Investor, and the Investor
desires to exchange with the Company, the Existing Securities for a new convertible 7.25% Debenture convertible into shares of
Common Stock set forth on the Investor’s signature page hereto (the “Debenture” or the “Exchange
Securities”); and

 

NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and in consideration
of the premises and the mutual agreements, representations and warranties, provisions and covenants contained herein, the parties
hereto, intending to be legally bound hereby, agree as follows:

 

1.
Exchange. On Closing Date (as defined below), subject to the terms and conditions of this Agreement, the Investor shall,
and the Company shall, pursuant to Section 3(a) (9) of the Securities Act, exchange the Existing Securities for the Exchange Securities.
Subject to the conditions set forth herein, the exchange of the Existing Securities for the Exchange Securities shall take place
at the offices of Sheppard, Mullin, Richter & Hampton, LLP or at such other place as the Company and the Investor mutually
agree (the “Closing” and such date, the “Closing Date”). At the Closing, the
following transactions shall occur (such transaction an “Exchange”):

 

1.1
On the Closing Date, in exchange for the Existing Securities, the Company shall deliver Exchange Securities to the Investor or
its designee in accordance with the Investor’s delivery instructions set forth on the Investor signature page hereto. Upon
receipt of the Exchange Securities in accordance with this Section 1.1, all of the Investor’s rights under the Existing
Securities shall be extinguished. The Investor shall tender to the Company the Existing Securities within three Trading Days (as
defined below) of the Closing Date.

 

1.2
On the Closing Date, the Investor shall be deemed for all corporate purposes to have become the holder of record of the Exchange
Securities, irrespective of the date such Exchange Securities are delivered to the Investor in accordance herewith. The Existing
Securities shall be deemed for all corporate purposes to have been cancelled upon receipt of the Exchange Securities in accordance
with Section 1.1 above. Until the Existing Securities have been delivered to the Company, the Investor shall bear the risk that
they are acquired by a bona fide purchaser with no notice of the Investor’s and the Company’s claims.

 

    	 

     

    

 

As
used herein, “Common Stock” means the common stock of the Company, par value $0.001 per share, and any
other class of securities into which such securities may hereafter be reclassified or changed.

 

As
used herein, “Person” means an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or
other entity of any kind.

 

As
used herein, “Trading Day” means any day on which the Common Stock is traded on the principal securities
exchange or securities market on which the Common Stock is then traded.

 

1.3
The Company and the Investor shall execute and/or deliver such other documents and agreements as are customary and reasonably
necessary to effectuate the Exchanges, including, at the request of the Company or its transfer agent, executed stock powers in
customary form.

 

2.
Closing Conditions.

 

2.1
Conditions to Investor’s Obligations. The obligation of the Investor to consummate the Exchange is subject to the
fulfillment, to the Investor’s reasonable satisfaction, prior to or at the Closing, of each of the following conditions:

 

(a)
Representations and Warranties. The representations and warranties of the Company contained in this Agreement shall be
true and correct in all material respects on the date hereof and on and as of the Closing Date as if made on and as of such date.

 

(b)
Issuance of the Debenture. At the Closing, the Company shall cause the Debenture to be delivered to the Investor at the
delivery address set forth on the signature page hereto.

 

(c)
No Actions. No action, proceeding, investigation, regulation or legislation shall have been instituted, threatened or proposed
before any court, governmental agency or authority or legislative body to enjoin, restrain, prohibit or obtain substantial damages
in respect of, this Agreement or the consummation of the transactions contemplated by this Agreement.

 

(d)
Proceedings and Documents. All proceedings in connection with the transactions contemplated hereby and all documents and
instruments incident to such transactions shall be satisfactory in substance and form to the Investor, and the Investor shall
have received all such counterpart originals or certified or other copies of such documents as they may reasonably request.

 

(e)
Consents. The Company shall have obtained all required consents, as set forth on Schedule 3.5.

 

    	2

     

    

 

2.2
Conditions to the Company’s Obligations. The obligation of the Company to consummate the Exchange is subject to the
fulfillment, to the Company’s reasonable satisfaction, prior to or at the Closing, of each of the following conditions:

 

(a)
Representations and Warranties. The representations and warranties of the Investor contained in this Agreement shall be
true and correct in all material respects on the date hereof and on and as of the Closing Date as if made on and as of such date.

 

(b)
No Actions. No action, proceeding, investigation, regulation or legislation shall have been instituted, threatened or proposed
before any court, governmental agency or authority or legislative body to enjoin, restrain, prohibit, or obtain substantial damages
in respect of, this Agreement or the consummation of the transactions contemplated by this Agreement.

 

(c)
Proceedings and Documents. All proceedings in connection with the transactions contemplated hereby and all documents and
instruments incident to such transactions shall be satisfactory in substance and form to the Company and the Company shall have
received all such counterpart originals or certified or other copies of such documents as the Company may reasonably request.

 

3.
Representations and Warranties of the Company. The Company hereby represents and warrants to Investor that:

 

3.1
Organization, Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good
standing under the laws of the State of Delaware. The Company is duly qualified to transact business and is in good standing in
each jurisdiction in which the failure to so qualify would have a material adverse effect on its business or properties.

 

3.2
Authorization. All corporate action on the part of the Company, its officers, directors and stockholders necessary for
the authorization, execution and delivery of this Agreement and the performance of all obligations of the Company hereunder, and
the authorization (or reservation for issuance of), the Exchange Securities and the underlying shares of Common Stock, and the
issuance of the Exchange Securities, have been taken on or prior to the date hereof.

 

3.3
Valid Issuance of the Debenture and Common Stock. The Debenture, when issued, will be a valid and binding obligation of
the Company. The shares of Common Stock issuable upon conversion of the Debenture, when issued and delivered in accordance with
the terms of the Debenture, for the consideration expressed herein, will be duly and validly issued, fully paid and non-assessable.

 

3.4
Compliance With Laws. The Company has not violated any law or any governmental regulation or requirement which violation
has had or would reasonably be expected to have a material adverse effect on its business and the Company has not received written
notice of any such violation.

 

    	3

     

    

 

3.5
Consents; Waivers. Other than as set forth on Schedule 3.5 attached hereto, no consent, waiver, approval or authority
of any nature, or other formal action, by any Person, not already obtained, is required in connection with the execution and delivery
of this Agreement by the Company or the consummation by the Company of the transactions provided for herein and therein.

 

3.6
Acknowledgment Regarding Investor’s Purchase of Securities. The Company acknowledges and agrees that the Investor
is acting solely in the capacity of arm’s length Investor with respect to this Agreement and the other documents entered
into in connection herewith (collectively, the “Transaction Documents”) and the transactions contemplated
hereby and thereby and that the Investor is not (i) an officer or director of the Company, (ii) an “affiliate” of
the Company (as defined in Rule 144 promulgated under the Securities Act), or (iii) to the knowledge of the Company, a “beneficial
owner” of more than 10% of the shares of Common Stock (as defined for purposes of Rule 13d-3 of the Securities Exchange
Act of 1934, as amended). The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary
of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby
and thereby, and any advice given by the Investor or any of its representatives or agents in connection with the Transaction Documents
and the transactions contemplated hereby and thereby is merely incidental to the Investor’s acceptance of the Exchange Securities.
The Company further represents to the Investor that the Company’s decision to enter into the Transaction Documents has been
based solely on the independent evaluation by the Company and its representatives.

 

3.7
Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board,
government agency, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting
the Company, the Securities or any of the Company’s officers or directors in their capacities as such.

 

3.8
Validity; Enforcement; No Conflicts. This Agreement and each Transaction Document to which the Company is a party have
been duly and validly authorized, executed and delivered on behalf of the Company and shall constitute the legal, valid and binding
obligations of the Company enforceable against the Company in accordance with their respective terms, except as such enforceability
may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.
The execution, delivery and performance by the Company of this Agreement and each Transaction Document to which the Company is
a party and the consummation by the Company of the transactions contemplated hereby and thereby will not (i) result in a violation
of the organizational documents of the Company or (ii) conflict with, or constitute a default (or an event which with notice or
lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture or instrument to which the Company is a party or by which it is bound, or (iii) result in a violation
of any law, rule, regulation, order, judgment or decree (including federal and state securities or “blue sky” laws)
applicable to the Company, except in the case of clause (ii) above, for such conflicts, defaults or rights which would not, individually
or in the aggregate, reasonably be expected to have a material adverse effect on the ability of the Company to perform its obligations
hereunder.

 

    	4

     

    

 

3.9
Disclosure. The Company confirms that neither it nor any other Person acting on its behalf has provided the Investor or
its agents or counsel with any information that constitutes or could reasonably be expected to constitute material, nonpublic
information. The Company understands and confirms that the Investor will rely on the foregoing representations in effecting transactions
in the Exchange Securities.

 

3.10
No Commission Paid. Neither the Company nor any of its affiliates nor any Person acting on behalf of or for the benefit
of any of the foregoing, has paid or given, or agreed to pay or give, directly or indirectly, any commission or other remuneration
(within the meaning of Section 3(a) (9) of the Securities Act and the rules and regulations of the Securities and Exchange Commission
promulgated thereunder) for soliciting the Exchange.

 

4.
Representations and Warranties of the Investor. The Investor hereby represents, warrants and covenants that:

 

4.1
Authorization. The Investor has full power and authority to enter into this Agreement, to perform its obligations hereunder
and to consummate the transactions contemplated hereby and has taken all action necessary to authorize the execution and delivery
of this Agreement, the performance of its obligations hereunder and the consummation of the transactions contemplated hereby.

 

4.2
Investment Experience. The Investor can bear the economic risk of its investment in the Securities, and has such knowledge
and experience in financial and business matters that it is capable of evaluating the merits and risks of an investment in the
Exchange Securities.

 

4.3
Information. The Investor and its advisors, if any, have been furnished with all materials relating to the business, finances
and operations of the Company and materials relating to the offer and issuance of the Exchange Securities which have been requested
by the Investor. The Investor has had the opportunity to review the Company’s filings with the Securities and Exchange Commission.
The Investor and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Neither such inquiries
nor any other due diligence investigations conducted by the Investor or its advisors, if any, or its representatives shall modify,
amend or affect the Investor’s right to rely on the Company’s representations and warranties contained herein. The
Investor understands that its investment in the Exchange Securities involves a high degree of risk. The Investor has sought such
accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition
of the Exchange Securities. The Investor is relying solely on its own accounting, legal and tax advisors, and not on any statements
of the Company or any of its agents or representatives, for such accounting, legal and tax advice with respect to its acquisition
of the Exchange Securities and the transactions contemplated by this Agreement.

 

4.4
No Governmental Review. The Investor understands that no United States federal or state agency or any other government
or governmental agency has passed on or made any recommendation or endorsement of the Exchange Securities or the fairness or suitability
of the investment in the Shares nor have such authorities passed upon or endorsed the merits of the offering of the Exchange Securities.

 

    	5

     

    

 

4.5
Validity; Enforcement; No Conflicts. This Agreement and each Transaction Document to which the Investor is a party have
been duly and validly authorized, executed and delivered on behalf of the Investor and shall constitute the legal, valid and binding
obligations of the Investor enforceable against the Investor in accordance with their respective terms, except as such enforceability
may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.
The execution, delivery and performance by the Investor of this Agreement and each Transaction Document to which the Investor
is a party and the consummation by the Investor of the transactions contemplated hereby and thereby will not (i) result in a violation
of the organizational documents of the Investor or (ii) conflict with, or constitute a default (or an event which with notice
or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Investor is a party, or (iii) result in a violation of any
law, rule, regulation, order, judgment or decree (including federal and state securities or “blue sky” laws) applicable
to the Investor, except in the case of clause (ii) above, for such conflicts, defaults or rights which would not, individually
or in the aggregate, reasonably be expected to have a material adverse effect on the ability of the Investor to perform its obligations
hereunder.

 

5.
Additional Covenants.

 

5.1
Disclosure. The Company shall, on or before 9:30 a.m., New York City time, on the first business day after the date of
this Agreement, issue a Current Report on Form 8-K (the “8-K Filing”) disclosing all material terms
of the transactions contemplated hereby. From and after the issuance of the 8-K Filing, the Investor shall not be in possession
of any material, nonpublic information received from the Company or any of its respective officers, directors, employees or agents
that is not disclosed in the 8-K Filing. The Company shall not, and shall cause its officers, directors, employees and agents,
not to, provide the Investor with any material, nonpublic information regarding the Company from and after the filing of the 8-K
Filing without the express written consent of the Investor. The Company shall not disclose the name of the Investor in any filing,
announcement, release or otherwise, unless such disclosure is required by law or regulation. In addition, effective upon the filing
of the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement,
whether written or oral, between the Company, any of its subsidiaries or any of their respective officers, directors, affiliates,
employees or agents, on the one hand, and the Investor or any of its affiliates, on the other hand, shall terminate.

 

5.2
Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts,
if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance
of this Agreement.

 

    	6

     

    

 

5.3
Section 3(a)(9) Exchange. The parties acknowledge and agree that in accordance with
Section 3(a)(9) of the Securities Act, the Shares shall take on the registered characteristics of the Exchange Securities being
exchanged. The Company agrees not to take any position contrary to this Section 5.3.

 

6.
Miscellaneous.

 

6.1
Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to
the benefit of and be binding upon the parties hereto and the respective successors and assigns of the parties. Nothing in this
Agreement, express or implied, is intended to confer upon any party, other than the parties hereto or their respective successors
and assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided
in this Agreement.

 

6.2
Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law
or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state or federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any
such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or
proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served
in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY
WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION
WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

6.3
Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered
in construing or interpreting this Agreement.

 

6.4
Notices. All notices, requests, claims, demands, waivers and other communications hereunder shall be in writing and shall
be deemed to have been duly given when delivered by hand, when delivered by courier, three days after being deposited in the mail
(registered or certified mail, postage prepaid, return receipt requested), or when received by email attachment, as set forth
on the signature pages hereto. Any party hereto, by notice given to the other parties hereto in accordance with this Section 6.4
may change the address or facsimile transmission number to which such notice or other communications are to be sent to such party.

 

    	7

     

    

 

6.5
Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may
be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent
of the Company and the Investor. Any amendment or waiver effected in accordance with this paragraph shall be binding upon Investor
and the Company, provided that no such amendment shall be binding on a holder that does not consent thereto to the extent such
amendment treats such party differently than any party that does consent thereto.

 

6.6
Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision
shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded
and shall be enforceable in accordance with its terms.

 

6.7
Entire Agreement. This Agreement represents the entire agreement and understanding between the parties concerning the Exchange
and the other matters described herein and therein and supersede and replaces any and all prior agreements and understandings
solely with respect to the subject matter hereof and thereof.

 

6.8
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument.

 

6.9
Interpretation. Unless the context of this Agreement clearly requires otherwise, (a) references to the plural include the
singular, the singular the plural, the part the whole, (b) references to any gender include all genders, (c) “including”
has the inclusive meaning frequently identified with the phrase “but not limited to” and (d) references to “hereunder”
or “herein” relate to this Agreement.

 

6.10
No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

6.11
Survival. The representations, warranties and covenants of the Company and the Investor contained herein shall survive
the Closing and delivery of the Exchange Securities.

 

6.12
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

6.13
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to
express their mutual intent, and no rules of strict construction will be applied against any party.

 

[SIGNATURES
ON THE FOLLOWING PAGES]

 

    	8

     

    

 

IN
WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and delivered as of the date provided above.

 

	 	THE
    COMPANY
	 	 
	 	AMERI
    HOLDINGS, INC.
	 	 	 
	 	By:	                     
	 	Name:	 
	 	Title:	 
	 	 	 
	 	Address
    for Notices:
	 	 
	 	Email:

 

    	9

     

    

 

IN
WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and delivered as of the date provided above.

 

INVESTOR

 

Name
of Investor:

 

Signature
of Authorized Signatory of Investor: __________________________________

 

Name
of Authorized Signatory: ____________________________________________________

 

Title
of Authorized Signatory: _____________________________________________________

 

Email
Address of Authorized Signatory: _____________________________________________

 

Instructions
for Delivery of Debenture to Investor:___________________________________________

 

    	10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]